Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details 3)

v3.23.1
Summary of Significant Accounting Policies (Details 3) - shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents 2,801,117 1,422,251
Employee Stock Option 1 [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents 385,257 37,641
Warrant 1 [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents 2,415,860 1,384,610